Isotope selection for patients undergoing prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 2, 1999, Pages 391-395

  Cha, Christine M ^a   Potters, Louis ^a   Ashley, Richard ^b   Freeman, Katherine ^c   Wang, Xiao Hong ^a   Waldbaum, Robert ^d   Leibel, Steven ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Rockville Centre   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Brachytherapy; Iodine 125; Palladium 103; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM; RADIOISOTOPE;

ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOBIOLOGY;

ANALYSIS OF VARIANCE; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MATCHED-PAIR ANALYSIS; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032839579     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00187-X     Document Type: Article

References (20)

1. Ragde H., Elgamal A.A., Snow P.B., et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
2. Beyer D.C., Priestley J.B. Jr. Biochemical disease-free survival following 125I prostate implantation. Int J Radiat Oncol Biol Phys. 37:1997;559-563.
3. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 14:1996;449-453.
4. Stock R.G., Stone N.N., DeWyngaert J.K., Lavagnini P., Unger P.D. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer. 77:1996;2386-2392.
5. Dattoli M., Wallner K., Sorace R., et al. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma [see comments]. Int J Radiat Oncol Biol Phys. 35:1996;875-879.
6. Nag S., Scaperoth D.D., Badalament R., Hall S.A., Burgers J. Transperineal palladium 103 prostate brachytherapy Analysis of morbidity and seed migration . Urology. 45:1995;87-92.
7. Blasko J.C., Ragde H., Grimm P.D. Transperineal ultrasound-guided implantation of the prostate Morbidity and complications . Scand J Urol Nephrol Suppl. 137:1991;113-118.
8. Ling C.C. Permanent implants using Au-198, Pd-103 and I-125 Radiobiological considerations based on the linear quadratic model . Int J Radiat Oncol Biol Phys. 23:1992;81-87.
9. Prestidge B.R. Radioisotopic implantation for carcinoma of the prostate Does it work better than it used to? Semin Radiat Oncol. 8:1998;124-131.
10. Fleming ID, Cooper JS, Henson DE; et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
11. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep. 50:1966;125-128.
12. Nath R., Anderson L.L., Meli J.A., Olch A.J., Stitt J.A., Williamson J.F. Code of practice for brachytherapy physics Report of the AAPM Radiation Therapy Committee Task Group No. 56; American Association of Physicists in Medicine . Med Phys. 24:1997;1557-1598.
13. Anderson L.L., Moni J.V., Harrison L.B. A nomograph for permanent implants of palladium-103 seeds. Int J Radiat Oncol Biol Phys. 27:1993;129-135.
14. Unger P.D., Hoon V., Stone N., et al. Computerized interactive morphometry in the differential diagnosis of irradiated prostates. Anal Quant Cytol Histol. 17:1995;100-108.
15. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
16. Cox D.R., Abadir R. Regression models and life tables. J Roy Statist Soc. 34:1972;187-220.
17. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Cancer Res Clin Oncol. 53:1958;447-457.
18. Hall EJ. Radiobiology for the radiologist. 3rd ed. Philadelphia: J.B. Lippincott; 1988.
19. Helpap B., Stiens R., Bruhl P. The proliferative pattern of the prostatic carcinoma before and under hormonal treatment. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 87:1976;311-320.
20. Prestidge B.R., Prete J.J., Buchholz T.A., et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys. 40:1998;461-465.